The Discounted Cash Flow (DCF) valuation of Jiangsu Kanion Pharmaceutical Co Ltd (600557.SS) is 12.18 CNY. With the latest stock price at 15.89 CNY, the upside of Jiangsu Kanion Pharmaceutical Co Ltd based on DCF is -23.3%.
Based on the latest price of 15.89 CNY and our DCF valuation, Jiangsu Kanion Pharmaceutical Co Ltd (600557.SS) is a sell. selling 600557.SS stocks now will result in a potential gain of 23.3%.
| Range | Selected | |
| WACC / Discount Rate | 8.0% - 11.2% | 9.6% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 10.04 - 16.57 | 12.18 |
| Upside | -36.8% - 4.3% | -23.3% |